Rare Analyte Recovery
Technologies developed for cfDNA, cfRNA, total cell-free nucleic acid, and circulating tumor cell workflows.
COMPANY · ABOUT nRichDX
Advancing liquid biopsy sample preparation.
nRichDX develops technologies designed to maximize recovery of rare analytes from liquid biopsy samples.
Based in Irvine, California, nRichDX provides kits and automated solutions for isolation of rare cfDNA, cfRNA, and circulating tumor cells from blood, plasma, urine, and other biofluids.
HEADQUARTERED IN
Irvine, California
01
OUR FOCUS
Recover more of what matters.
Sample preparation designed around rare-analyte recovery.
A LEADER IN LIQUID BIOPSY SAMPLE PREP
The sample comes first.
Liquid biopsy assays depend on the molecular material recovered before downstream analysis begins.
nRichDX develops the Revolution Sample Prep platform to help researchers and laboratories isolate rare analytes from liquid-biopsy samples while reducing workflow steps that can contribute to recovery loss.
THE REVOLUTION PLATFORM
Built around recovery
WHO WE ARE
Technology built for the sample-preparation challenge.
nRichDX provides kits and automated solutions for maximizing isolation of rare cfDNA, cfRNA, and CTCs.
The patented Revolution Sample Prep System is engineered for liquid biopsy applications and supports analyte isolation from blood, plasma, urine, and other biofluids.
Revolution supports sample volumes from 1 mL to 100 mL in a single extraction using patented nRicher Cartridges, helping laboratories work across a broad range of sample-volume requirements.
Explore the Revolution Platform
WHAT DEFINES nRichDX
Sample preparation designed around recovery, flexibility, and workflow.
The Revolution platform addresses the upstream sample-preparation step where valuable molecular material can be lost before an assay ever sees it.
Broad Sample Flexibility
Support for blood, plasma, urine, and other biofluids across diverse liquid-biopsy applications.
Volume Range
Revolution workflows support sample volumes from 1 mL to 100 mL in a single extraction, depending on the application.
Fewer Handling Steps
Cartridge-based workflows are designed to reduce manual preconcentration, pooling, transfers, and re-elution steps.
WHY SAMPLE PREPARATION MATTERS
You can’t detect what you don’t recover.
The quantity and quality of molecular material entering a downstream assay help define what that assay has the opportunity to detect. nRichDX focuses on the upstream workflow so laboratories can evaluate sample input, recovery, and automation as part of assay development and implementation.
Explore Scientific Reference Materials
01
Sample Input
02
Molecular Recovery
03
Downstream Analysis
THE TECHNOLOGY FOUNDATION
The Revolution platform
A cartridge-based sample-preparation architecture designed to support liquid-biopsy workflows from research through increasing levels of automation.
Explore the Platform
TECHNOLOGY FOUNDATION
nRicher Cartridge
Single-use cartridge architecture at the center of Revolution sample preparation.
SAMPLE PREPARATION
Revolution Systems
Workflow options designed to support research, development, and automation needs.
WORKFLOW EVOLUTION
Scale Toward Automation
Move from sample-preparation development toward more standardized automated workflows.
OUR PEOPLE
Meet the leadership behind nRichDX.
Explore the teams and advisors helping guide the company, its technology, and its scientific direction.
nRichDX HEADQUARTERS
Innovation in Irvine, California.
nRichDX is headquartered in Southern California, supporting customers, collaborators, and researchers working to advance liquid biopsy workflows.
CONNECT WITH nRichDX